Asadi, Mehdi; Ebrahimi, Mostafa; Mohammadi-Khanaposhtani, Maryam; Azizian, Homa; Sepehri, Saghi; Nadri, Hamid; Biglar, Mahmood; Amanlou, Massoud; Larijani, Bagher; Mirzazadeh, Roghieh; Edraki, Najmeh; Mahdavi, Mohammad published an article in 2019, the title of the article was Design, synthesis, molecular docking, and cholinesterase inhibitory potential of phthalimide-dithiocarbamate hybrids as new agents for treatment of Alzheimer’s disease.Product Details of 574-98-1 And the article contains the following content:
A novel series of phthalimide-dithiocarbamate hybrids was synthesized and evaluated for in vitro inhibitory potentials against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The anti-cholinesterase results indicated that among the synthesized compounds, the compounds 7g and 7h showed the most potent anti-AChE and anti-BuChE activities, resp. Mol. docking and dynamic studies of the compounds 7g and 7h, resp., in the active site of AChE and BuChE revealed that these compounds as well interacted with studied cholinesterases. These compounds also possessed drug-like properties and were able to cross the BBB. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Product Details of 574-98-1
The Article related to synthesis docking cholinesterase inhibitor phthalimide dithiocarbamate hybrid antialzheimer, alzheimer’s disease, acetylcholinesterase, butyrylcholinesterase, dithiocarbamate, inhibitory activity, phthalimide and other aspects.Product Details of 574-98-1
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary